aibioAGIO Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals (AGIO) news
Top story · Jul 30, 2026 · SEC filing 8-K
Agios Pharmaceuticals reports results
Latest Agios Pharmaceuticals news
We have not published a story on Agios Pharmaceuticals yet. When there is news, it will appear here.
Agios Pharmaceuticals annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $339.5 million | $301.3 million |
| Net income (loss) | -$412.8 million | $673.7 million |
| Cash from operations | -$373.0 million | -$389.8 million |
| Cash and equivalents | $89.1 million | $76.2 million |
| Short-term investments | $765.3 million | $817.5 million |
Questions about Agios Pharmaceuticals
What is the ticker symbol of Agios Pharmaceuticals?
Agios Pharmaceuticals, Inc. trades under the ticker AGIO on NASDAQ.
Where is Agios Pharmaceuticals listed?
Agios Pharmaceuticals, Inc. is listed on NASDAQ. Our directory also records these other listings: GETTEX:8AP; LSE:0HB0; LSX:A1W2RM.
What is the SEC CIK of Agios Pharmaceuticals?
The SEC Central Index Key (CIK) for Agios Pharmaceuticals, Inc. is 1439222. Its filings are on SEC EDGAR.
How many shares does Agios Pharmaceuticals have outstanding?
59,701,882 shares as of 2026-07-24, per the cover page of its 10-Q filed 2026-07-30.
Which country or territory is Agios Pharmaceuticals listed under?
Our directory records Agios Pharmaceuticals, Inc. under United States.
What does Agios Pharmaceuticals do?
Our directory classifies Agios Pharmaceuticals, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Agios Pharmaceuticals?
The ISIN recorded for Agios Pharmaceuticals, Inc. is US00847X1046.
Does aibio.space cover Agios Pharmaceuticals?
aibio.space lists Agios Pharmaceuticals, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Agios Pharmaceuticals incorporated?
SEC records list its state or country of incorporation as DE.
Is Agios Pharmaceuticals profitable?
Agios Pharmaceuticals, Inc. reported a net loss of $412.8 million for the fiscal year ended Dec 31, 2025, and used $373.0 million of cash in operations, per its annual report to the SEC.
How much does Agios Pharmaceuticals spend on research and development?
$339.5 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Agios Pharmaceuticals have?
$617.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
What is Agios Pharmaceuticals's market cap?
We do not publish live share prices. In its annual report, Agios Pharmaceuticals, Inc. put the market value of shares held by non-affiliates (public float) at $1.91 billion as of Jun 30, 2025.
Is Agios Pharmaceuticals a smaller reporting company?
SEC records list Agios Pharmaceuticals, Inc.'s filer category as: Large accelerated filer.
Where is Agios Pharmaceuticals headquartered?
SEC records list its business address as 88 SIDNEY STREET, CAMBRIDGE, MA, 02139.
Investor discussion: Agios Pharmaceuticals
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
SEC filings and registration
- SEC name
- Agios Pharmaceuticals, Inc.
- CIK
- 1439222
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- AGIO (Nasdaq)
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- Filer category
- Large accelerated filer
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Phone
- 617-649-8600
- Shares outstanding
- 59,701,882 as of 2026-07-24 (10-Q filed 2026-07-30)
- Former names
- AGIOS PHARMACEUTICALS INC
Recent filings
Listing details
- Company
- Agios Pharmaceuticals, Inc.
- Ticker
- AGIO
- Listing
- NASDAQ
- Country or territory
- United States
- Business scope
- Pharmaceuticals: Major
- ISIN
- US00847X1046
- Other listed symbols
- GETTEX:8AP; LSE:0HB0; LSX:A1W2RM
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction